Clinical Trial Update: Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) [Phase 3]

View source ↗

Summary

Open-label extension study update for plecanatide in chronic idiopathic constipation completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation

Drugs mentioned

• Plecanatide (plecanatide)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Chronic Idiopathic Constipation | Phase 3 | Status: COMPLETED | Results posted: 2019-07-02